Summary
Updated Aug 31, 2026
Susan L. Kelley is Director of Dare Bioscience, Inc. (DARE). 3 SEC Form 4 filings on record going back to 2025, most recently on 2 July 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Susan L. Kelley has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Susan L. Kelley's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Michael B. Petras Jr. - $33.51M of SHC open-market activity in the last 12 months
- Reuven Yeganeh - $33.32M of PHGE open-market activity in the last 12 months
- Adage Capital Management, L.P. - $33.20M of PRAX open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $33.00M of REPL open-market activity in the last 12 months
- Casdin Capital, LLC - $32.57M of WGS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Susan L. Kelley?
Susan L. Kelley is a corporate insider, tracked as Director of Dare Bioscience, Inc. (DARE). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Susan L. Kelley submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Susan L. Kelley's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Susan L. Kelley and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
